Not Signed In -
Dopamine |
Intropin |
This article or section is in need of attention from an expert on the subject. Please help recruit one, or improve this page yourself if you can. See discussion page for details. This article or section may be confusing or unclear for some readers, and should be edited to rectify this. Please improve the article, or discuss the issue on the talk page. For other uses, see Dopamine (disambiguation). Dopamine General Systematic name 4-(2-aminoethyl)benzene-1,2-diol Other names 2- ...
Wikipedia - [full article]
Dopamine Clinical Trials
- Embryonic Dopamine Cell Implants for Parkinson's Disease: A Double-Blind Study
ClinicalTrials.gov Identifier: NCT00038116 - Active, not recruiting
Parkinson Disease
- How the loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
ClinicalTrials.gov Identifier: NCT00040196 - Recruiting
Parkinson Disease
- Donor Dopamine and Initial Graft Function
ClinicalTrials.gov Identifier: NCT00115115 - Recruiting
Kidney Transplantation; ESRD
- OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine
ClinicalTrials.gov Identifier: NCT00401999 - Recruiting
Alcoholism
- Impact of Switching to Continuous Release Dopamine Agonists
ClinicalTrials.gov Identifier: NCT00465452 - Recruiting
Parkinson Disease
- Dopamine Receptor Imaging in Mood Disorders
ClinicalTrials.gov Identifier: NCT00116077 - Recruiting
- Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
ClinicalTrials.gov Identifier: NCT00225498 - Recruiting
Schizophrenia
- Brain Dopamine Function in Adults With ADHD
ClinicalTrials.gov Identifier: NCT00580814 - Recruiting
Attention Deficit Hyperactivity Disorder
- A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.
ClinicalTrials.gov Identifier: NCT00396669 - Recruiting
Tobacco Use Disorder
- Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson''s Disease Progression
ClinicalTrials.gov Identifier: NCT00134784 - Active, not recruiting
Parkinson''s Disease
- Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
ClinicalTrials.gov Identifier: NCT00000276 - Active, not recruiting
Cocaine-Related Disorders
- Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-Moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
ClinicalTrials.gov Identifier: NCT00566462 - Recruiting
Parkinson's Disease
- Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
ClinicalTrials.gov Identifier: NCT00443872 - Recruiting
Parkinson's Disease
- Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
ClinicalTrials.gov Identifier: NCT00000350 - Active, not recruiting
Amphetamine-Related Disorders; Tobacco Use Disorder
- Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
ClinicalTrials.gov Identifier: NCT00471588 - Recruiting
Obsessive-Compulsive Disorder
- The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
ClinicalTrials.gov Identifier: NCT00581009 - Recruiting
Major Depressive Disorder; Bipolar Disorder
- Dopamine and Norepinephrine in Shock Patients
ClinicalTrials.gov Identifier: NCT00314704 - Recruiting
Shock
- Dopamine Function in Developmental Stuttering
ClinicalTrials.gov Identifier: NCT00024960 - Active, not recruiting
Developmental Stuttering
- Potentiation of Procedural Motor Learning in Health and Disease
ClinicalTrials.gov Identifier: NCT00126087 - Recruiting
Stroke; Aging
- An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD
ClinicalTrials.gov Identifier: NCT00302380 - Recruiting
Attention Deficit Hyperactivity Disorder
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
ClinicalTrials.gov Identifier: NCT00335205 - Recruiting
Bipolar Disorder; Major Depressive Disorder
- Examining the Usage of Dopamine Blockers in OCD Patients
ClinicalTrials.gov Identifier: NCT00496925 - Not yet recruiting
Obsessive Compulsive Disorder
- Relationship of Dopamine to Cognitive Function in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00094601 - Recruiting
Parkinson Disease
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00153972 - Recruiting
Parkinson''s Disease
- A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
ClinicalTrials.gov Identifier: NCT00480246 - Recruiting
Healthy
- D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation
ClinicalTrials.gov Identifier: NCT00173446 - Recruiting
Hypertension; Adrenal Aldosterone-Producing Adenoma
- Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists
ClinicalTrials.gov Identifier: NCT00196898 - Recruiting
Heart Valve Diseases; Parkinson's Disease
- Domperidone as a Treatment for Dopamine Agonist-Induced Peripheral Edema in Patients With Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00305331 - Recruiting
Parkinson's Disease; Peripheral Edema
- Role of Dopamine in Response to Alcohol
ClinicalTrials.gov Identifier: NCT00050219 - Completed
- A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults
ClinicalTrials.gov Identifier: NCT00301639 - Completed
Healthy Volunteers
- An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects
ClinicalTrials.gov Identifier: NCT00302367 - Completed
Healthy Volunteers
- PET Imaging of Dopamine in Healthy Study Participants
ClinicalTrials.gov Identifier: NCT00062946 - Completed
Healthy
- The Effect of Dopamine on Motor Skills Training
ClinicalTrials.gov Identifier: NCT00067275 - Completed
Cerebrovascular Accident
- Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients
ClinicalTrials.gov Identifier: NCT00001320 - Completed
Healthy; Schizophrenia
- Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112
ClinicalTrials.gov Identifier: NCT00088517 - Completed
Healthy
- The Role of Dopamine in Motor Learning in Healthy Subjects and Patients with Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00032812 - Completed
Parkinson Disease; Healthy
- Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
ClinicalTrials.gov Identifier: NCT00000315 - Completed
Cocaine-Related Disorders
- Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
ClinicalTrials.gov Identifier: NCT00000316 - Completed
Cocaine-Related Disorders
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects with Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00129181 - Completed
Parkinson Disease; Parkinsonian Syndrome
- Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
ClinicalTrials.gov Identifier: NCT00209456 - Completed
Lewy Body Dementia; Non-DLB Dementia; Alzheimer’s; Vascular Dementia
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00096720 - Completed
Parkinson Disease; Parkinsonian Syndrome
- Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
ClinicalTrials.gov Identifier: NCT00000309 - Terminated
Cocaine-Related Disorders
- Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
ClinicalTrials.gov Identifier: NCT00000310 - Terminated
Cocaine-Related Disorders
email this page
print this page
bookmark this page
feedback on this page
